Although it is well known that the irreversible dysregulation of the proliferation, migration and invasion of FLS cells (which can be effectively adjusted by the TNF-α and IL-1β neutralizing antibodies that are used clinically) plays critical roles in RA, the detailed mechanisms are still far from clear. The gene discussed is TNF; the disease is rheumatoid arthritis.